Enza Palazzo Selected Research

Respiratory Hypersensitivity

1/2015

Exposure to Allergen Causes Changes in NTS Neural Activities after Intratracheal Capsaicin Application, in Endocannabinoid Levels and in the Glia Morphology of NTS.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Enza Palazzo Research Topics

Disease

32	Pain (Aches) 01/2022 - 05/2004
24	Neuralgia (Stump Neuralgia) 01/2021 - 10/2006
22	Hyperalgesia 01/2022 - 05/2004
9	Chronic Pain 01/2021 - 08/2010
5	Cognitive Dysfunction 01/2021 - 06/2015
3	Peripheral Nerve Injuries 01/2021 - 01/2011
2	Mood Disorders (Mood Disorder) 01/2022 - 03/2004
2	Mental Disorders (Mental Disorder) 01/2019 - 01/2016
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017 - 02/2014
1	Weight Gain 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2021
1	Neurobehavioral Manifestations 01/2021
1	Epilepsy (Aura) 01/2017
1	Brain Concussion (Cerebral Concussion) 01/2017
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2015
1	Ataxia (Dyssynergia) 02/2015
1	Bronchial Hyperreactivity 01/2015
1	Respiratory Hypersensitivity 01/2015
1	Acute Pain 01/2015
1	Asthma (Bronchial Asthma) 01/2015
1	Nervous System Diseases (Neurological Disorders) 02/2014
1	Arthritis (Polyarthritis) 12/2011
1	Visceral Pain 04/2011
1	Inflammation (Inflammations) 01/2011

Drug/Important Bio-Agent (IBA)

13	Glutamic Acid (Glutamate)FDA Link 01/2021 - 05/2004
12	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2020 - 09/2008
8	metabotropic glutamate receptor 7IBA 01/2020 - 09/2008
8	Analgesics (Analgesic Drugs)IBA 01/2018 - 12/2007
7	metabotropic glutamate receptor 8IBA 01/2020 - 09/2008
6	LigandsIBA 01/2017 - 08/2010
5	Serotonin (5 Hydroxytryptamine)IBA 10/2015 - 05/2004
5	Formaldehyde (Formol)FDA Link 09/2013 - 05/2004
4	gamma-Aminobutyric Acid (GABA)IBA 01/2021 - 07/2007
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 09/2019 - 12/2009
4	palmidrolIBA 04/2019 - 01/2011
4	CarrageenanIBA 03/2013 - 05/2004
4	CannabinoidsIBA 03/2012 - 10/2006
4	EndocannabinoidsIBA 03/2012 - 03/2006
3	salicylhydroxamic acid (SHAM)IBA 04/2019 - 10/2015
3	PlasticsIBA 01/2015 - 01/2011
3	Cannabinoid Receptors (Cannabinoid Receptor)IBA 08/2012 - 08/2010
3	TRPV1 receptorIBA 10/2010 - 04/2008
3	anandamide (arachidonylethanolamide)IBA 01/2009 - 10/2006
2	2-pentadecyl-2-oxazolineIBA 01/2022 - 01/2021
2	Histamine H3 Receptors (Histamine H3 Receptor)IBA 01/2022 - 01/2021
2	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2022 - 01/2021
2	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 10/2015
2	Metabotropic Glutamate 5 ReceptorIBA 04/2019 - 05/2004
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2018 - 03/2011
2	N,N'-dibenzhydrylethane-1,2-diamine dihydrochlorideIBA 01/2018 - 12/2011
2	D-Aspartic Acid (D Aspartate)IBA 01/2016 - 01/2015
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 03/2011
2	Mesylates (Mesylate)IBA 03/2012 - 10/2006
1	2- amino- 4- (3- hydroxy- 5- methylisoxazol- 4- yl)butyric acidIBA 01/2022
1	Heavy MetalsIBA 06/2021
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2021
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2021
1	LY 235959IBA 09/2019
1	Glutamate Receptors (Glutamate Receptor)IBA 09/2019
1	N-Methylaspartate (NMDA)IBA 09/2019
1	Neuroprotective AgentsIBA 04/2019
1	N-acylethanolaminesIBA 01/2019
1	metabotropic glutamate receptor 2IBA 01/2018
1	metabotropic glutamate receptor 3 (mGluR3)IBA 01/2018
1	ADX71743IBA 01/2018
1	Amitriptyline (Elavil)FDA LinkGeneric 01/2016
1	Homer Scaffolding Proteins (Homer 1)IBA 01/2016
1	SolutionsIBA 01/2016
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2016
1	7- hydroxy- 3- (4- iodophenoxy)- 4H- chromen- 4- oneIBA 06/2015
1	N- (2- ((3- bromophenyl)- (4- fluorophenyl)amino)ethyl)acetamideIBA 02/2015
1	MT2 Melatonin ReceptorIBA 02/2015
1	acetamideIBA 02/2015
1	Gabapentin (Neurontin)FDA LinkGeneric 02/2015
1	OvalbuminIBA 01/2015
1	AllergensIBA 01/2015
1	GABA-A Receptors (GABA(A) Receptor)IBA 03/2013
1	metabotropic glutamate receptor type 1IBA 03/2013
1	BicucullineIBA 03/2013
1	AMPA Receptors (AMPA Receptor)IBA 11/2012
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 11/2012
1	CaspasesIBA 11/2012
1	salvinorin AIBA 08/2012
1	CationsIBA 02/2012
1	ONO-DI-004IBA 10/2011
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 04/2011
1	ProdrugsIBA 04/2011
1	Arginine (L-Arginine)FDA Link 04/2011
1	Monosaccharide Transport ProteinsIBA 04/2011
1	EstersIBA 04/2011
1	vesicular GABA transporterIBA 03/2011
1	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 01/2011
1	arachidonoylserotoninIBA 01/2011

Therapy/Procedure

5	Analgesia 01/2022 - 12/2009
3	Ligation 01/2021 - 02/2015
2	Therapeutics 01/2017 - 01/2011
1	Operative Surgical Procedures 01/2018
1	Pain Management 02/2012